Socioeconomic disparities and multidrug-resistant tuberculosis in South Korea: Focus on immigrants and income levels

Han Eol Jeong; Sungho Bea; Ju Hwan Kim; Seung Hun Jang; Hyunjin Son; Ju-Young Shin

doi:10.1016/j.jmii.2022.08.014

Socioeconomic disparities and multidrug-resistant tuberculosis in South Korea: Focus on immigrants and income levels

J Microbiol Immunol Infect. 2023 Apr;56(2):424-428. doi: 10.1016/j.jmii.2022.08.014. Epub 2022 Sep 7.

Authors

Han Eol Jeong¹, Sungho Bea², Ju Hwan Kim¹, Seung Hun Jang³, Hyunjin Son⁴, Ju-Young Shin⁵

Affiliations

¹ School of Pharmacy, Sungkyunkwan University, Suwon, South Korea; Department of Biohealth Regulatory Science, Sungkyunkwan University, Suwon, South Korea.
² School of Pharmacy, Sungkyunkwan University, Suwon, South Korea.
³ Division of Pulmonary, Allergy, and Critical Care Medicine, College of Medicine, Hallym University Sacred Heart Hospital, Hallym University College of Medicine, Anyang, South Korea.
⁴ Department of Preventive Medicine, College of Medicine, Dong-A University, Busan, South Korea.
⁵ School of Pharmacy, Sungkyunkwan University, Suwon, South Korea; Department of Biohealth Regulatory Science, Sungkyunkwan University, Suwon, South Korea; Department of Clinical Research Design & Evaluation, Samsung Advanced Institute for Health Sciences & Technology, Sungkyunkwan University, Seoul, South Korea. Electronic address: shin.jy@skku.edu.

PMID: 36115791
DOI: 10.1016/j.jmii.2022.08.014

Abstract

Risk factors of MDR-TB remain unclear in South Korea, despite being an important public health issue. Findings from this study, which included ≥50,000 patients with TB from South Korea, suggests that immigrants and patients with lower income levels were strong predictors of MDR-TB in a high-income, high TB incidence country.

Keywords: Disparities; Multidrug-resistant tuberculosis; Predictors; Socioeconomic; Tuberculosis.

MeSH terms

Antitubercular Agents / pharmacology
Antitubercular Agents / therapeutic use
Emigrants and Immigrants*
Humans
Mycobacterium tuberculosis*
Republic of Korea / epidemiology
Risk Factors
Socioeconomic Disparities in Health
Tuberculosis, Multidrug-Resistant* / drug therapy
Tuberculosis, Multidrug-Resistant* / epidemiology

Substances

Antitubercular Agents